{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:44:35Z","timestamp":1777286675312,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201909193"],"award-info":[{"award-number":["tsqn201909193"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"jining research and development program","award":["2023YXNS013"],"award-info":[{"award-number":["2023YXNS013"]}]},{"DOI":"10.13039\/100018935","name":"Lin He's New Medicine and Clinical Translation Academician Workstation Research Fund","doi-asserted-by":"publisher","award":["JYHL2021ZD03"],"award-info":[{"award-number":["JYHL2021ZD03"]}],"id":[{"id":"10.13039\/100018935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13258-026-01743-1","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:49:49Z","timestamp":1770623389000},"page":"595-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of genetic mutation characteristics in 40 Chinese patients with hepatocellular carcinoma"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7159-9292","authenticated-orcid":false,"given":"Shaoshao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Xun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"1743_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB et al (2013) Signatures of mutational processes in human cancer. Nature 500:415\u2013421","journal-title":"Nature"},{"key":"1743_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/4286228","volume":"2024","author":"S Aslam","year":"2024","unstructured":"Aslam S et al (2024) Potential target metabolites from gut microbiota against hepatocellular carcinoma: a network pharmacology and molecular docking study. Int J Microbiol 2024:4286228","journal-title":"Int J Microbiol"},{"key":"1743_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/imt.10.107","volume":"3","author":"EV Barsov","year":"2011","unstructured":"Barsov EV (2011) Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy. Immunotherapy 3:407\u2013421","journal-title":"Immunotherapy"},{"key":"1743_CR4","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.3390\/curroncol31100471","volume":"31","author":"D Bian","year":"2024","unstructured":"Bian D, Cohen SF, Lazaratos AM, Bouganim N, Dankner M (2024) Antibody-drug conjugates for the treatment of non-small cell lung cancer with central nervous system metastases. Curr Oncol 31:6314\u20136342","journal-title":"Curr Oncol"},{"key":"1743_CR5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114\u20132120","journal-title":"Bioinformatics"},{"key":"1743_CR6","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012118","volume":"12","author":"C Brueffer","year":"2020","unstructured":"Brueffer C et al (2020) The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome. EMBO Mol Med 12:e12118","journal-title":"EMBO Mol Med"},{"key":"1743_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030817","author":"C Campani","year":"2023","unstructured":"Campani C, Zucman-Rossi J, Nault JC (2023) Genetics of hepatocellular carcinoma: from tumor to circulating DNA. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15030817","journal-title":"Cancers (Basel)"},{"key":"1743_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00830-w","volume":"13","author":"BZ Carter","year":"2023","unstructured":"Carter BZ et al (2023) Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics. Blood Cancer J 13:57","journal-title":"Blood Cancer J"},{"key":"1743_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR et al (2017) Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med 9:34","journal-title":"Genome Med"},{"key":"1743_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41575-019-0240-9","volume":"17","author":"B Chen","year":"2020","unstructured":"Chen B et al (2020) Harnessing big \u2018omics\u2019 data and AI for drug discovery in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 17:238\u2013251","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1743_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.21037\/atm-21-6754","volume":"10","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Yang J, Wang D, Yan D (2022) ROS1 fusion lung adenosquamous carcinoma patient with short-term clinical benefit after crizotinib treatment: a case report. Ann Transl Med 10:157","journal-title":"Ann Transl Med"},{"key":"1743_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051052","author":"S Cherri","year":"2021","unstructured":"Cherri S et al (2021) Drug-related pneumonitis in cancer treatment during the COVID-19 era. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13051052","journal-title":"Cancers (Basel)"},{"key":"1743_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K et al (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31:213\u2013219","journal-title":"Nat Biotechnol"},{"key":"1743_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082048","volume":"12","author":"LI der Stroth","year":"2020","unstructured":"der Stroth LI, Tharehalli U, G\u00fcnes C, Lechel A (2020) Telomeres and telomerase in the development of liver cancer. Cancers 12:2048","journal-title":"Cancers"},{"key":"1743_CR15","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.21037\/jgo-21-312","volume":"12","author":"X Duan","year":"2021","unstructured":"Duan X et al (2021) The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds. J Gastrointest Oncol 12:1786\u20131796","journal-title":"J Gastrointest Oncol"},{"key":"1743_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton GM et al (2013) Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31:1023\u20131031","journal-title":"Nat Biotechnol"},{"key":"1743_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102457","volume":"14","author":"G Froyen","year":"2022","unstructured":"Froyen G, Geerdens E, Berden S, Cruys B, Maes B (2022) Diagnostic validation of a comprehensive targeted panel for broad mutational and biomarker analysis in solid tumors. Cancers 14:2457","journal-title":"Cancers"},{"key":"1743_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ng.2291","volume":"44","author":"A Fujimoto","year":"2012","unstructured":"Fujimoto A et al (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44:760\u2013764","journal-title":"Nat Genet"},{"key":"1743_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/genes15040396","volume":"15","author":"V Gupta","year":"2024","unstructured":"Gupta V et al (2024) Comprehensive analysis of clinically relevant copy number alterations (CNAs) using a 523-gene next-generation sequencing panel and NxClinical software in solid tumors. Genes 15:396","journal-title":"Genes"},{"key":"1743_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/cells9030749","volume":"9","author":"F Hafezi","year":"2020","unstructured":"Hafezi F, Perez BD (2020) The solo play of TERT promoter mutations. Cells 9:749","journal-title":"Cells"},{"key":"1743_CR21","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause RJ, Pritchard CC, Shendure J, Salipante SJ (2016) Classification and characterization of microsatellite instability across 18 cancer types. Nat Med 22:1342\u20131350","journal-title":"Nat Med"},{"key":"1743_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357","journal-title":"Nat Protoc"},{"key":"1743_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41419-017-0114-4","volume":"9","author":"Y Huang","year":"2018","unstructured":"Huang Y et al (2018) Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma. Cell Death Dis 9:141","journal-title":"Cell Death Dis"},{"key":"1743_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092160","volume":"13","author":"J Jang","year":"2021","unstructured":"Jang J et al (2021) Significance of TERT genetic alterations and telomere length in hepatocellular carcinoma. Cancers 13:2160","journal-title":"Cancers"},{"key":"1743_CR25","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M (2021) KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49:D545\u2013D551","journal-title":"Nucleic Acids Res"},{"key":"1743_CR26","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.7150\/thno.71676","volume":"12","author":"NA Kaya","year":"2022","unstructured":"Kaya NA et al (2022) Genome instability is associated with ethnic differences between Asians and Europeans in hepatocellular carcinoma. Theranostics 12:4703\u20134717","journal-title":"Theranostics"},{"key":"1743_CR27","doi-asserted-by":"publisher","first-page":"12438","DOI":"10.1002\/cam4.5953","volume":"12","author":"J Kim","year":"2023","unstructured":"Kim J, Jung J, Kim K, Lee J, Im Y (2023b) TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors. Cancer Med 12:12438\u201312451","journal-title":"Cancer Med"},{"key":"1743_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4143\/crt.2022.891","volume":"55","author":"M Kim","year":"2023","unstructured":"Kim M et al (2023a) Validation and clinical application of ONCOaccuPanel for targeted next-generation sequencing of solid tumors. Cancer Res Treat 55:429\u2013441","journal-title":"Cancer Res Treat"},{"key":"1743_CR29","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC et al (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22:568\u2013576","journal-title":"Genome Res"},{"key":"1743_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122871","author":"M Komuta","year":"2021","unstructured":"Komuta M (2021) Histological heterogeneity of primary liver cancers: clinical relevance, diagnostic pitfalls and the pathologist\u2019s role. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13122871","journal-title":"Cancers (Basel)"},{"key":"1743_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac261","volume":"23","author":"J Li","year":"2022","unstructured":"Li J et al (2022) Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization. Brief Bioinform 23:bbac261","journal-title":"Brief Bioinform"},{"key":"1743_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.121","volume":"12","author":"JM Llovet","year":"2015","unstructured":"Llovet JM, Villanueva A, Lachenmayer A, Finn RS (2015) Advances in targeted therapies for hepatocellular carcinoma in the genomic era. Nat Rev Clin Oncol 12:436","journal-title":"Nat Rev Clin Oncol"},{"key":"1743_CR33","doi-asserted-by":"publisher","first-page":"82273","DOI":"10.18632\/oncotarget.12701","volume":"7","author":"O Lombardi","year":"2016","unstructured":"Lombardi O, Varshney D, Phillips NM, Cowling VH (2016) C-Myc deregulation induces mRNA capping enzyme dependency. Oncotarget 7:82273\u201382288","journal-title":"Oncotarget"},{"key":"1743_CR34","first-page":"189","volume":"9","author":"L Ma","year":"2025","unstructured":"Ma L, Chen S, Wang H, Chen L (2025) Hepatitis B virus integration and hepatocarcinogenesis. Liver Res (Beijing, China) 9:189\u2013198","journal-title":"Liver Res (Beijing, China)"},{"key":"1743_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrg2841","volume":"11","author":"M Meyerson","year":"2010","unstructured":"Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11:685\u2013696","journal-title":"Nat Rev Genet"},{"key":"1743_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41593-018-0303-1","volume":"22","author":"ME Montchal","year":"2019","unstructured":"Montchal ME, Reagh ZM, Yassa MA (2019) Precise temporal memories are supported by the lateral entorhinal cortex in humans. Nat Neurosci 22:284\u2013288","journal-title":"Nat Neurosci"},{"key":"1743_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinre.2015.07.006","volume":"40","author":"J Nault","year":"2016","unstructured":"Nault J, Zucman-Rossi J (2016) TERT promoter mutations in primary liver tumors. Clin Res Hepatol Gastroenterol 40:9\u201314","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1743_CR38","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00535-023-02037-z","volume":"58","author":"Y Ozono","year":"2023","unstructured":"Ozono Y, Kawakami H, Uchiyama N, Hatada H, Ogawa S (2023) Current status and issues in genomic analysis using EUS-FNA\/FNB specimens in hepatobiliary-pancreatic cancers. J Gastroenterol 58:1081\u20131093","journal-title":"J Gastroenterol"},{"key":"1743_CR39","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gutjnl-2023-330414","volume":"73","author":"Z Qian","year":"2024","unstructured":"Qian Z et al (2024) HBV integrations reshaping genomic structures promote hepatocellular carcinoma. Gut 73:1169\u20131182","journal-title":"Gut"},{"key":"1743_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","volume":"19","author":"JS Ross","year":"2014","unstructured":"Ross JS et al (2014) New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. Oncologist 19:235\u2013242","journal-title":"Oncologist"},{"key":"1743_CR41","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.3390\/curroncol30060439","volume":"30","author":"SM Ruff","year":"2023","unstructured":"Ruff SM et al (2023) Current landscape of immune checkpoint inhibitor therapy for hepatocellular carcinoma. Curr Oncol 30:5863\u20135875","journal-title":"Curr Oncol"},{"key":"1743_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K et al (2015) Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 47:505\u2013511","journal-title":"Nat Genet"},{"key":"1743_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08765-w","volume":"21","author":"C Shi","year":"2021","unstructured":"Shi C, Liu S, Tian X, Wang X, Gao P (2021) A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma. BMC Cancer 21:1035","journal-title":"BMC Cancer"},{"key":"1743_CR44","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.02.98","volume":"8","author":"M Shi","year":"2020","unstructured":"Shi M et al (2020) Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma. Ann Transl Med 8:321","journal-title":"Ann Transl Med"},{"key":"1743_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1743_CR46","doi-asserted-by":"publisher","first-page":"34811","DOI":"10.18632\/oncotarget.9187","volume":"7","author":"M Suenaga","year":"2016","unstructured":"Suenaga M et al (2016) Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer. Oncotarget 7:34811\u201334823","journal-title":"Oncotarget"},{"key":"1743_CR47","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1743_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091216","author":"S Tavolari","year":"2023","unstructured":"Tavolari S, Brandi G (2023) Mutational landscape of cholangiocarcinoma according to different etiologies: a review. Cells. https:\/\/doi.org\/10.3390\/cells12091216","journal-title":"Cells"},{"key":"1743_CR49","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM et al (2018) Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33:676-689.e3","journal-title":"Cancer Cell"},{"key":"1743_CR50","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/14656566.2017.1349100","volume":"18","author":"N Uy","year":"2017","unstructured":"Uy N, Singh A, Gore SD, Prebet T (2017) Hypomethylating agents (HMA) treatment for myelodysplastic syndromes: alternatives in the frontline and relapse settings. Expert Opin Pharmacother 18:1213\u20131224","journal-title":"Expert Opin Pharmacother"},{"key":"1743_CR51","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1182\/blood.2022016428","volume":"140","author":"M Vanden Bempt","year":"2022","unstructured":"Vanden Bempt M et al (2022) Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma. Blood 140:2463\u20132476","journal-title":"Blood"},{"key":"1743_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04799-9","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C et al (2023b) Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis. J Transl Med 21:919","journal-title":"J Transl Med"},{"key":"1743_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173069","volume":"16","author":"C Wang","year":"2024","unstructured":"Wang C, Tan JYM, Chitkara N, Bhatt S (2024) TP53 mutation-mediated immune evasion in cancer: mechanisms and therapeutic implications. Cancers 16:3069","journal-title":"Cancers"},{"key":"1743_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ajcp\/aqad078","volume":"160","author":"D Wang","year":"2023","unstructured":"Wang D et al (2023a) Validation and benchmarking of targeted panel sequencing for cancer genomic profiling. Am J Clin Pathol 160:507\u2013523","journal-title":"Am J Clin Pathol"},{"key":"1743_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.21037\/hbsn.2019.09.17","volume":"10","author":"S Wang","year":"2021","unstructured":"Wang S et al (2021) Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary Surg Nutr 10:172\u2013179","journal-title":"Hepatobiliary Surg Nutr"},{"key":"1743_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16:589\u2013604","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1743_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834992","volume":"12","author":"K Ye","year":"2022","unstructured":"Ye K et al (2022) Prognostic value of postoperative circulating tumor DNA in patients with early- and intermediate-stage hepatocellular carcinoma. Front Oncol 12:834992","journal-title":"Front Oncol"},{"key":"1743_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657575","volume":"12","author":"QJ Zhang","year":"2021","unstructured":"Zhang QJ et al (2021) Age-related differences in molecular profiles for immune checkpoint blockade therapy. Front Immunol 12:657575","journal-title":"Front Immunol"},{"key":"1743_CR59","first-page":"221","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS et al (2024) Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi [chin J Oncol] 46:221\u2013231","journal-title":"Zhonghua Zhong Liu Za Zhi [chin J Oncol]"},{"key":"1743_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000488035","volume":"7","author":"J Zhou","year":"2018","unstructured":"Zhou J et al (2018) Guidelines for diagnosis and treatment of primary liver cancer in China. Liver Cancer 7:235\u2013260","journal-title":"Liver Cancer"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-026-01743-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:03:49Z","timestamp":1777284229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-026-01743-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1007\/s13258-026-01743-1","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Studies involving human participants were reviewed and approved by the ethics committee of the Affiliated Hospital of Jining Medical University (Ethics code: 2021C145). All the patients provided written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this manuscript, the authors utilized ChatGPT (OpenAI, GPT-3.5 model accessed May 2024) for language editing. The authors critically reviewed all the AI-processed content and accepted full responsibility for the final work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration on the use of generative AI in manuscript preparation"}}]}}